"10.1371_journal.pmed.1001433","plos medicine","2013-04-23T00:00:00Z","Fengju Song; Abrar A Qureshi; Edward L Giovannucci; Charlie S Fuchs; Wendy Y Chen; Meir J Stampfer; Jiali Han","Department of Epidemiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States of America; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America","Conceived and designed the experiments: JH. Analyzed the data: FS. Contributed reagents/materials/analysis tools: AQ EG CF WC MS JH. Wrote the first draft of the manuscript: FS. Contributed to the writing of the manuscript: FS AQ EG CF WC MS JH. ICMJE criteria for authorship read and met: FS AQ EG CF WC MS JH. Agree with manuscript results and conclusions: FS AQ EG CF WC MS JH.","AQ declares the following: Pfizer - Questionnaire licensed for clinical trials; research grant. Merck - Questionnaire licensed for clinical trials. Amgen - Research grant. Abbott - Consulting. US Centers for Disease Control - Consulting. Janssen - Consulting. Novartis - Consulting. All other authors have declared that no competing interests exist.","2013","04","Fengju Song","FS",7,FALSE,1,NA,1,1,TRUE,TRUE,FALSE,0,NA,FALSE
